Potential role of flavonoids in the prevention of intestinal neoplasia

A review of their mode of action and their clinical perspectives
Research Article


Intestinal neoplasia (adenomas and carcinomas) can possibly be prevented by a diet rich in vegetables and fruits, treatment with aspirin and other nonsteroidal antiinflammatory drugs, and early colonoscopic removal of adenomas. Ballast, fiber, and secondary plant products could play a major role in colon cancer prevention. Recently there has been much experimental work in vitro and in vivo about flavonoids as inducers of bioprevention. Flavonoids are secondary plant products with a wide variety of beneficial biological properties, and they possess anticarcinogenic, antimutagenic, and antioxidative modes of actions. Flavonoids are the main components of a healthy diet containing fruits and vegetables and are concentrated especially in tea, apples, and onions. We will focus this review on flavonoids which are derived from tea products such as proanthocyanidins (green tea) and flavons (camomille tea). Oral supplementation with bioflavonoids derived from tea could be used in humans to prevent growth of intestinal neoplasia such as adenomatous polyps of the colon. Flavonoids are a large group of natural compounds of which only a few have been used in animal models, cell cultures, and enzyme studies to inhibit mutagenic and carcinogenic events. Their clinical mode of action was evaluated by epidemiological studies, but no intervention studies in humans have been performed so far. In vitro flavonoids can bind electrophils, inactivate oxygen radicals, prevent lipid peroxidation, and inhibit DNA oxidation. In cell cultures they increase the rate of apoptosis, inhibit cell proliferation, and angiogenesis. In vivo they can induce the activities of protective enzymes (conjugating enzymes such as glutathione transferases and glucuronosyl transferases) of the intestine and the liver. In models of intestinal polyposis, flavonoids suppress polyp formation. Some epidemiological studies show a protective effect of flavonoids contained in fruits, vegetables, and tea.Flavonoid mixtures of tea origin supplied as nutritional supplements could be studied as a new way of bioprevention of intestinal neoplasia (colon adenomas and cancer). Therefore, a controlled, randomized clinical study should be performed to evaluate the efficacy of flavonoids.

Key Words

Flavonoids intestinal neoplasia nonsteroidal antiinflammatory drugs 


  1. 1.
    Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and metaanalysis. Lancet 2004;364:1219–1228.PubMedCrossRefGoogle Scholar
  2. 2.
    Johnson IT. New approaches to the role of diet in the prevention of cancers of the alimentary tract. Mutat Res 2004;551(1–2):9–28.PubMedGoogle Scholar
  3. 3.
    Ferguson LR, Philpott M, Karunasinghe N. Dietary cancer and prevention using antimutagens. Toxicology 2004;198(1–3):147–159.PubMedCrossRefGoogle Scholar
  4. 4.
    Aherne SA, O’Brien NM. Dietary flavonols: chemistry, food content, and metabolism. Nutrition 2002;18:75–81.PubMedCrossRefGoogle Scholar
  5. 5.
    Roos JA, Kasum CM. Dietary flavonoids: bioavialability, metabolic effects and safety. Ann Rev Nutr 2002;22:19–34.CrossRefGoogle Scholar
  6. 6.
    Yang CS, Malaikal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002;33:237–253.Google Scholar
  7. 7.
    World Cancer Research Fund. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Menasha, WI: Banta Book Group, 1997.Google Scholar
  8. 8.
    Pufulete M, Al-Ghnaniem R, Leather AJM, et al. Folate status, genomic DNA hypomethylation and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 2003;124:1240–1248.PubMedCrossRefGoogle Scholar
  9. 9.
    Baron J A, Cole B F, Sandler R S, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;348:891–899.PubMedCrossRefGoogle Scholar
  10. 10.
    Benamouzig R, Deyra J, Martin A, et al. Daily soluble aspririn and prevention of colorectal adenome recurrence: one year results of the APACC trial. Gastroenterology 2003;125:328–336.PubMedCrossRefGoogle Scholar
  11. 11.
    Rahme E, Barkun AN, Toubout Y, et al. The cyclooxygenase 2-inhibitors Rofecoxib and Celecoxib prevent colorectal neoplasia occurence. Gastroenterology 2003;125:404–421.PubMedCrossRefGoogle Scholar
  12. 12.
    Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;348:883–890.PubMedCrossRefGoogle Scholar
  13. 13.
    Knekt P, Jarvinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidem 1997;146:223–230.Google Scholar
  14. 14.
    Yang CS, Landau JM, Huang MT, et al. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutri 2001;21:381–406.CrossRefGoogle Scholar
  15. 15.
    Paradi DS, Loftus EV, Kremers WK, et al. Ursodesoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003;124:889–893.CrossRefGoogle Scholar
  16. 16.
    Burt RW. Colon cancer screening. Gastroenterology 2000;119:837–853.PubMedCrossRefGoogle Scholar
  17. 17.
    Liebermann DA, Weiss DG, Bond JH. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162–168.CrossRefGoogle Scholar
  18. 18.
    Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med 2000;342:1156–1162.PubMedCrossRefGoogle Scholar
  19. 19.
    Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low fat, high fiber diet on the recurrence of colorectal adenomas. N Engl J Med 2000;342:1149–1155.PubMedCrossRefGoogle Scholar
  20. 20.
    Lacy AM, Garcia-Valdecasas JC, Delgado S. Laparoscopy assisted colectomy versus open colectomy for treatment of nonmetastatic colon cancer: a randomised trial. Lancet 2002;359:2224–2229.PubMedCrossRefGoogle Scholar
  21. 21.
    Galati G, Moridani MY, Chan TS, O’Brian PJ. Cancer chemoprevention and apoptotis mechanisms induced by dietary polyphenolics. Drug Metab Drug Interact 2000;17:311–349.Google Scholar
  22. 22.
    Manthey JA, Grohmann K, Gutherie N. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem 2001;8:135–153.PubMedGoogle Scholar
  23. 23.
    Greenberg RE, Baron JA, Tosteson TD. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994, 331:141–147.PubMedCrossRefGoogle Scholar
  24. 24.
    Kent TJ, Allen NE, Spencer EA, et al. The effect of diet on risk of cancer. Lancet 2002;360:861–868.CrossRefGoogle Scholar
  25. 25.
    Suleiman S, Rex OK, Sonnenberg A. Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis. Gastroenterology 2002;122:78–84.PubMedCrossRefGoogle Scholar
  26. 26.
    Bertram B, Bartsch H. Krebsprävention durch grünen Tee: Wirklichkeit und Wunschdenken. Wien Med Wochenschr 2002, 516:153–158.CrossRefGoogle Scholar
  27. 27.
    Kuo SM. Dietary flavonoids and cancer prevention: evidence and potential mechanism. Crit Rev Oncol 1997;8:47–69.Google Scholar
  28. 28.
    Witte JS, Longnecker MP, Bird CL, Lee ER, Frankl HD, Haile RW. Relation of vegetable, fruit and grain consumption to colorectal adenomatous polyps. Am J Epidem 1996;144:1015–1027.Google Scholar
  29. 29.
    Setiawan VW, Chang F, Yu GP. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer 2001;92:600–604.PubMedCrossRefGoogle Scholar
  30. 30.
    Dorant E, van den Brandt PA, Goldbohm RA, Sturmans F. Consumption of onoins and a reduced risk of stomach carcinoma. Gastroenterology 1996;110:141–147.CrossRefGoogle Scholar
  31. 31.
    Arts IC, Jacobs DR Jr, Gross M, Harnack LJ, Folsom AR. Dietary catechins and cancer incidence among postmenopausal women: the Iowa women’s health study. Cancer Causes Control 2002;13:373–382.PubMedCrossRefGoogle Scholar
  32. 32.
    Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary flavonoids and cancer risk in the Zuitphen Elderly Study. Nutr Cancer 1994;22:175–184.PubMedCrossRefGoogle Scholar
  33. 33.
    Goldbohm RA, et al. Flavonoid intake and risk of cancer: a prospective cohort study. Am J Epidem Suppl 1995;141:61S.Google Scholar
  34. 34.
    Michels KB, Edward G, Joshipura KJ, et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst 2000;92:1740–1752.PubMedCrossRefGoogle Scholar
  35. 35.
    US Preventive Service Task Force. Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommodations and rationale. Ann Int Med 2003;139:51–70.Google Scholar
  36. 36.
    Riboli E, Norat T. Epidemiological evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003;78:559–569.Google Scholar
  37. 37.
    Goodlad R, Englyst HN. Redefining dietary fibre: potentially a recipe for disaster. Lancet 2001;358:1833–1834.PubMedCrossRefGoogle Scholar
  38. 38.
    Peters U, Sinha R, Chatterjee N, et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 2003;361:1491–1495.PubMedCrossRefGoogle Scholar
  39. 39.
    Bingham SA, Day NE, Luben R, et al. Dietary fiber in food and protection against colorectal cancer in the European Protective Investigation into Cancer and Nutrition: an observational study. Lancet 2003;1496–1501.Google Scholar
  40. 40.
    Hoensch H, Morgenstern I, Petereit G, et al. Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system. Gut 2002;50:235–240.PubMedCrossRefGoogle Scholar
  41. 41.
    Hoensch HP, Steinhardt HJ, Weiss H, et al. Effects of semisynthetic diets on the xenobiotic metabolizing enzyme activity and on morphology of small intestinal mucosa in humans. Gastroenterology 1984;86:1519–1530.PubMedGoogle Scholar
  42. 42.
    Steele VE, Kelloff GJ, Balentine D, et al. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro assays. Carcinogenesis 2000;21:63–67.PubMedCrossRefGoogle Scholar
  43. 43.
    Hara Y, Green tea, health benefits and applications, in Food Science and Technology. New York-Basel: Marcel Dekker, 2001.Google Scholar
  44. 44.
    Raab B, Jacobasch G, Heinevetter L, Maurer S. Role of flavonols and anthocyanins from fruits and vegetables in cancer prevention, in Phytochemicals and Phytopharmaceuticals. (Shahidi F, Ho C-T, eds.) Champaign, IL: AOCS Press, 2000, pp. 154–163.Google Scholar
  45. 45.
    Yamane T, Nakatani H, Kikuoka N, et al. Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. Cancer 1996;77:1662–1667.PubMedGoogle Scholar
  46. 46.
    Nijhoff WA, Groen GM, Peters WHM. Induction of rat hepatic and intestinal glutathion S-transferases and glutathione by dietary naturally occuring anticarcinogens. Int J Oncol 1993;1131–1139.Google Scholar
  47. 47.
    vander Logt EM, Roelofs HMJ, Nagengast FM, Peters WHM. Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis 2003;24:1651–1656.PubMedCrossRefGoogle Scholar
  48. 48.
    Salucci M, Stivala LA, Maiani G, et al. Flavonoid uptake and their effect on cell cycle of human colon adenocarcinoma cells. Brit J Cancer 2002;86:1645–1651.PubMedCrossRefGoogle Scholar
  49. 49.
    Duthie SJ, Dobson VL. Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro. Eur J Nutr 1999;38:28–34.PubMedCrossRefGoogle Scholar
  50. 50.
    Lautraite S, Musonda AC, Doehmer J, et al. Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP 1A2, CYP 1A1. Mutagenesis 2002;17(1):45–53.PubMedCrossRefGoogle Scholar
  51. 51.
    Kuntz S, Wenzel U, Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity and apoptosis in human cancer cell lines. Eur J Nutr 1999;38:133–142.PubMedCrossRefGoogle Scholar
  52. 52.
    Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone is a potent inducer in human carcinoma cells. Cancer Res 2000;60:3823–3831.PubMedGoogle Scholar
  53. 53.
    Grady WM. Genetic testing for high risk colon cancer patients. Gastroenterology 2003;124:1574–1594.PubMedCrossRefGoogle Scholar
  54. 54.
    Skibola CF, Smith MT. Potential health impacts of excessive flavonoid intake. Free Rad Biol Med 2000;29:375–383.PubMedCrossRefGoogle Scholar
  55. 55.
    Hayes JD, McLellen LI. Glutathione and glutathionedependent enzymes represent a coordinately regulated defence against oxidative stress. Free Rad Res 1999;31:273–300.CrossRefGoogle Scholar
  56. 56.
    Evans RC, Fear S, Ashby D, et al. Diet and colorectal cancer:an investigation of the lectin / galactose hypothesis. Gastroenterology 2002;122:1784–1792.PubMedCrossRefGoogle Scholar
  57. 57.
    Slattery ML, Edwarts S, Curtin K, et al. Physical activity and colorectal cancer. Am J Epidemiol 2003;158:214–224.PubMedCrossRefGoogle Scholar
  58. 58.
    Radtke J, Linseisen J, Wolfram G. Fasting plasma concentrations of selected flavonoids as biomarkers of their ordinary dietary intake. Eur J Nutr 2002;41:203–209.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2005

Authors and Affiliations

  1. 1.Department of Internal Medicine, Section of GastroenterologyCommunity Hospital of Gross-GerauGross-GerauGermany
  2. 2.Medical Faculty, Institut of Clinical PharmacologyTechnical University of DresdenDresdenGermany

Personalised recommendations